Genital vitiligo-like depigmentation following use of imiquimod 5% cream

European Journal of Dermatology

Volumn 18, Issue 3, 2008, Pages 342-343

  Vieira Serrão, Vasco ^a   Rocha Páris, Filipa ^a   Barata Feio, Ana ^a  

^a HOSPITAL DOS CAPUCHOS   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IMIQUIMOD; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AUTOIMMUNITY; CASE REPORT; CELL ACTIVATION; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DEPIGMENTATION; EDEMA; ERYTHEMA; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LETTER; MALE; TREATMENT REFUSAL; VITILIGO;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; ADULT; AMINOQUINOLINES; CONDYLOMATA ACUMINATA; HUMANS; MALE; PENILE DISEASES; PENIS; SKIN; VITILIGO;

EID: 44949230220     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0402     Document Type: Letter

References (6)

1. Schöfer H, Van Ophoven A, Henke U, Lenz T, Eul A. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts. Eur J Dermatol 2006; 16: 642-8.
2. Brown T, Zirvi M, Cotsarelis G, Gelfand JM. Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. J Am Acad Dermatol 2005; 52: 715-6.
3. Stefanaki C, Nicolaidou E, Hadjivassiliou M, et al. Imiquimod-induced vitiligo in a patient with genital warts. J Eur Acad Dermatol Venereol 2006; 20: 755-6.
4. Mendonca CO, Yates VM. Permanent facial hypopigmentation following treatment with imiquimod cream. Clin Exp Dermatol 2006; 31: 721-2.
5. Rajpar SF, Marsden JR. Imiquimod in the treatment of lentigo maligna. Br J Dermatol 2006; 155: 653-6.
6. Al-Dujaili Z, Hsu S. Imiquimod-induced vitiligo. Dermatol Online J 2007; 13: 10.